advanced search

Welcome: Guest

log in

Latin American Cardiovascular Drugs Markets

Publication Date January 2008
Publisher Frost & Sullivan
Product Type Report
Pages
ISBN Number not applicable
Product Code FRS00718
Buy this product or for assistance call +44 20 7060 7474

Summary

This research service covers the Latin America Cardiovascular drugs market from 2004 to 2011, with 2006 as the base year. Major markets were studied: Brazil and the Andean Region (which includes Colombia and Venezuela, countries that are estimated to achieve double digit growth rates in the forecast period).

Content

  • Market overview
    • Introduction
      • Executive summary
      • Research scope and methodology
      • Market segmentation
      • Glossary of terms
    • Overview
      • Overview of the latin american cardiovascular drugs markets
      • Market engineering measurements
      • Regulatory framework
  • Cardiovascular drugs markets in brazil
    • Market measurements
      • Market profile and measurements
      • Industry challenges
      • Market drivers
      • Market restraints
    • Antihypertensive drugs
      • Product measurements
      • Product pricing analysis
      • Competitive analysis
    • Antidyslipidemic drugs
      • Product measurements
      • Product pricing analysis
      • Competitive analysis
    • Other drugs (antithrombotics and antiarrhythmics)
      • Product measurements
      • Product pricing analysis
      • Competitive analysis
    • Product distribution analysis
      • Product distribution structure
    • Drug pipelines
      • Cardiovascular pipelines
  • Cardiovascular drugs markets in the andean region (colombia and venezuela)
    • Market measurements
      • Market profile and measurements
      • Industry challenges
      • Market drivers
      • Market restraints
    • Antihypertensive drugs
      • Product measurements
      • Product pricing analysis
      • Competitive analysis
    • Antidyslipidemic drugs
      • Product measurements
      • Product pricing analysis
      • Competitive analysis
    • Other drugs (antithrombotics and antiarrhythmics)
      • Product measurements
      • Product pricing analysis
      • Competitive analysis
    • Product distribution analysis
      • Product distribution structure
    • Drug pipelines
      • Cardiovascular pipelines
  • Decision support database
    • Decision support database
      • Total healthcare expenditure
      • Government healthcare expenditure
      • Private healthcare expenditure
      • Per capita healthcare expenditure
      • Pharmaceutical r&d expenditure
      • Prevalence of hypertension
Delivery Details

PDF:Delivered by email within 12 to 24 hours of placing the order (Mon-Fri